---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-023118"
form_type: "8-K"
ticker: "SYRA"
cik: "0001922335"
company_name: "Syra Health Corp"
filed_at: "2025-08-12T23:59:59+00:00"
generated_at: "2026-05-17T14:54:25.374545+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Syra Health Q2 net loss narrows 95% to $64K; gross margin surges to 38.7%

## Summary
- Net loss of $64K ($0.01 EPS) vs $1.4M loss ($0.21 EPS) in Q2 2024; adjusted EBITDA improved to ($54K) from ($1.4M).
- Gross margin rose 2,090 bps to 38.7%; operating expenses declined 53% YoY to $816K.
- Population Health revenue up 197% to $1.6M, driven by $5.8M FSSA contract for HCBS training.
- Cash $2.3M, no long-term debt; negotiating $5.8M CMHW mental health contract with Indiana FSSA.

## SEC filing metadata
- accession: 0001641172-25-023118
- form_type: 8-K
- ticker: SYRA
- cik: 0001922335
- company_name: Syra Health Corp
- filed_at: 2025-08-12T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1922335/000164117225023118/0001641172-25-023118-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1922335/000164117225023118/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-023118
- JSON: https://secwatch.observer/filing/0001641172-25-023118.json
- Plain text: https://secwatch.observer/filing/0001641172-25-023118.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.